About Us
International Supplier of
Naturally Derived
Psychoactive Products
About Us
International Supplier of
Naturally Derived
Psychoactive Products
Who We Are
PsyLabs develops and supplies naturally derived psychoactive products for research and clinical programs worldwide.
Our Approach
Combining scientific rigor, advanced extraction capabilities and pharmaceutical-grade manufacturing standards, we support researchers, clinicians and partners working at the forefront of new treatments for mental health.
Our Mission
Our mission is to help unlock the therapeutic potential of psychedelics through trusted quality, responsible innovation and globally relevant scientific collaboration.
What Drives Us
Psychedelic science holds transformative potential. We are committed to advancing this field with integrity, precision and a steadfast focus on improving mental health outcomes.
Standardised Botanical APIs and Products for Clinical Research
Psylabs operates federally licensed psychedelic cultivation and extraction facilities in Southern Africa. We export raw materials, extracts and active pharmaceutical ingredients (APIs) to a global network of research partners, clinical programs and biotech companies.
Licensed Production
Internationally
Licensed production of natural psychoactive compounds.
GMP-Compliant
Pathways
Supporting clinical and regulatory development through GMP Compliant Certification.
Specialists in
Controlled Substances
Focused on psilocybin, ibogaine and related compounds for research applications and special access programs
Research
Focused
Designed for clinical pathways and regulated access programs.
Standardised Botanical APIs and Products for Clinical Research
Psylabs operates federally licensed psychedelic cultivation and extraction facilities in Southern Africa and exports raw materials, extracts and active pharmaceutical ingredients (APIs) to research partners and pharmaceutical collaborators internationally.
Licensed Production
Internationally
Licensed production of
natural psychoactive compounds.
GMP-Compliant
Pathways
Supporting clinical and regulatory
development through
GMP Compliant Certification.
Specialists in
Controlled Substances
Focused on psilocybin,
ibogaine and related compounds
for research applications
and special access programs
Research
Focused
Designed for Clinical
pathways and
regulated access programs.
We focus on bridging natural product extraction with pharmaceutical standards through proprietary extraction, purification and stabilisation methodologies designed to support scalable, regulator-ready psychedelic therapeutics.
PsyLabs is federally licensed to cultivate, produce, and export psychedelic substances to the global medical market and the commercial medical research markets.
Our production and manufacturing facility in Southern Africa is ISO22000-certified, the highest standards available for mushroom cultivation. The facility has been fully operational for four years with a 24-hour production cycle and has recently completed and commissioned a major expansion to include pharmaceutical-grade extraction capabilities. Patents have been filed on the extract of purified Active Pharmaceutical Ingredient with additional IP in process. The management team has been working together for more than 5 years and have extensive experience in the controlled substances sector.
We focus on bridging natural product extraction with pharmaceutical standards through proprietary extraction, purification and stabilisation methodologies designed to support scalable, regulator-ready psychedelic therapeutics.
PsyLabs is federally licensed to cultivate, produce, and export psychedelic substances to the global medical market and the commercial medical research markets. Its commercial
ISO22000, the highest standards available for mushroom cultivation, facility in Southern Africa has been fully operational for four years with a 24-hour production cycle and has recently completed and commissioned a major expansion to include pharmaceutical-grade extraction capabilities. Patents have been filed on the extract of purified Active Pharmaceutical Ingredient with additional IP in process. The Management team has been working together for more than 5 years and have extensive experience in the controlled substances sector.
The Team
PsyLabs brings together global expertise across psychedelic cultivation, extraction science, pharmaceutical development, regulatory engagement and international business development.
The company works with scientific advisors, pharmaceutical manufacturing partners, clinical researchers and specialist consultants to support the progression of naturally derived psychoactive compounds into regulated medical and research markets globally.
OUR PEOPLE
The minds behind the science
A cross-disciplinary team of scientists, cultivators and clinicians advancing the next generation of neurotherapeutics.
Hover to explore, or click to keep a profile open
OUR PEOPLE
The minds behind the science
Our Values
PsyLabs is built on scientific rigor, pharmaceutical quality and responsible innovation. Our approach combines naturally derived product development with global collaboration, ethical sourcing and long-term regulatory readiness.
Scientific
Integrity
Evidence-based
research and scientifically
rigorous development
pathways.
Nature-Derived
Innovation
Advancing naturally
derived psychoactive
compounds through
modern science.
Ethical
Sourcing
Responsible cultivation
and ethical sourcing
practices across
supply chains.
Pharmaceutical
Quality
Commitment to
pharmaceutical-grade
manufacturing and
quality systems.
Global
Collaboration
Working with
international researchers,
clinicians and
development partners.
Regulatory
Readiness
Built for clinical
translation,
compliance and
scalable market access.
Intellectual
Property
Developing and
protecting differentiated
scientific and
product IP.
Our Values
PsyLabs is built on scientific rigor, pharmaceutical quality and responsible innovation.
Our approach combines naturally derived product development with global collaboration, ethical sourcing and long-term regulatory readiness.
Scientific
Integrity:
Evidence-based
research and scientifically
rigorous development
pathways.
Nature-Derived
Innovation:
Advancing naturally
derived psychoactive
compounds through
modern science.
Ethical
Sourcing:
Responsible cultivation
and ethical sourcing
practices across
supply chains.
Pharmaceutical
Quality:
Commitment to
pharmaceutical-grade
manufacturing and
quality systems.
Global
Collaboration:
Working with
international researchers,
clinicians and
development partners.
Regulatory
Readiness:
Built for clinical
translation,
compliance and
scalable market access.
Intellectual
Property:
Developing and
protecting differentiated
scientific and
product IP.
Partners
Strategic Partnerships for Research, Development and Commercialisation
Advancing innovative therapeutics requires collaboration across multiple disciplines. PsyLabs works closely with a network of leading organisations and specialists to support the development, manufacture, and progression of naturally derived psychoactive compounds.
PsyLabs works closely with:
Strategic partnerships support
